Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remington

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Schizophrenia Research|May 3, 1997
Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effectsL A Tugg, D Desai, P Prendergast, et al.
The American Journal of Psychiatry|July 1, 1996
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET studyS Kapur, G Remington, C Jones, et al.
Psychopharmacology|May 1, 1997
The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET studyS Kapur, R Zipursky, P Roy, et al.
Acta Psychiatrica Scandinavica|July 7, 2020
Adherence to clozapine vs. other antipsychotics in schizophreniaH Takeuchi, C Borlido, M Sanches, et al.
Schizophrenia Research|July 21, 2011
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficitsG Foussias, S Mann, K K Zakzanis, et al.
The American Journal of Psychiatry|July 11, 1998
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigationS Kapur, R B Zipursky, G Remington, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockadeP B Fitzgerald, S Kapur, M P Caligiuri, et al.
Schizophrenia Research|May 27, 2015
Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophreniaG Foussias, I Siddiqui, G Fervaha, et al.
Acta Psychiatrica Scandinavica|May 17, 2016
Clozapine administration in clinical practice: once-daily versus divided dosingH Takeuchi, V Powell, S Geisler, et al.
The American Journal of Psychiatry|August 2, 2001
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophreniaJ M Azorin, R Spiegel, G Remington, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Schizophrenia Research|May 3, 1997
Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effectsL A Tugg, D Desai, P Prendergast, et al.
The American Journal of Psychiatry|July 1, 1996
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET studyS Kapur, G Remington, C Jones, et al.
Psychopharmacology|May 1, 1997
The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET studyS Kapur, R Zipursky, P Roy, et al.
Acta Psychiatrica Scandinavica|July 7, 2020
Adherence to clozapine vs. other antipsychotics in schizophreniaH Takeuchi, C Borlido, M Sanches, et al.
Schizophrenia Research|July 21, 2011
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficitsG Foussias, S Mann, K K Zakzanis, et al.
The American Journal of Psychiatry|July 11, 1998
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigationS Kapur, R B Zipursky, G Remington, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 2000
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockadeP B Fitzgerald, S Kapur, M P Caligiuri, et al.
Schizophrenia Research|May 27, 2015
Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophreniaG Foussias, I Siddiqui, G Fervaha, et al.
Acta Psychiatrica Scandinavica|May 17, 2016
Clozapine administration in clinical practice: once-daily versus divided dosingH Takeuchi, V Powell, S Geisler, et al.
The American Journal of Psychiatry|August 2, 2001
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophreniaJ M Azorin, R Spiegel, G Remington, et al.
Pageof 10